Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Oddo BHF établit une recommandation surperformer sur Biomerieux et fixe un objectif de cours à 110 €.
The stock of bioMérieux, a French specialist in in vitro diagnostics, has had a tough week. The share price closed on Friday at 97.80 euros, marking a…
On Wednesday, January 28, bioMérieux shares recorded a significant decline of 2.79%, reaching 99.15 euros from 102 euros the previous day. This downtu…
The in vitro diagnostics group bioMérieux announced on Thursday the acquisition of the American company Accellix, which specializes in automated flow …
Biomerieux experienced a challenging week, with a decline of 8%, which starkly contrasts with the relative stability of major indices. The stock close…
bioMérieux shares closed on Wednesday, January 7th at 113.50 euros, marking a decline of 1.13% from the previous day, facing technical resistance at 1…
Biomérieux has announced the launch of a new product dedicated to the equine sector, according to a press release dated December 4, 2025.
bioMérieux's stock fell this Thursday at the close, down 2.77% to 105.40 euros. This decline came two days after the company's downward revision of it…
bioMérieux has announced a 7.3% increase in organic sales growth for the first nine months of the year, reaching 2,992 million euros, according to the…
Oxford Nanopore Technologies and bioMérieux have announced the launch of AmPORE-TB, a research use only (RUO) solution aimed at rapidly detecting muta…
